Mitotic MELK-eIF4B Signaling Controls Protein Synthesis and Tumor Cell Survival

Yubao Wang,Michael Begley,Qing Li,Hai-Tsang Huang,Ana Lako,Michael J. Eck,Nathanael S. Gray,Timothy J. Mitchison,Lewis C. Cantley,Jean J. Zhao

DOI: https://doi.org/10.1073/pnas.1606862113

2016-01-01

Abstract:The protein kinase maternal and embryonic leucine zipper kinase (MELK) is critical for mitotic progression of cancer cells; however, its mechanisms of action remain largely unknown. By combined approaches of immunoprecipitation/mass spectrometry and peptide library profiling, we identified the eukaryotic translation initiation factor 4B (eIF4B) as a MELK-interacting protein during mitosis and a bona fide substrate of MELK. MELK phosphorylates eIF4B at Ser406, a modification found to be most robust in the mitotic phase of the cell cycle. We further show that the MEL-KeIF4B signaling axis regulates protein synthesis during mitosis. Specifically, synthesis of myeloid cell leukemia 1 (MCL1), an antiapoptotic protein known to play a role in cancer cell survival during cell division, depends on the function of MELK-elF4B. Inactivation of MELK or eIF4B results in reduced protein synthesis of MCL1, which, in turn, induces apoptotic cell death of cancer cells. Our study thus defines a MELK-eIF4B signaling axis that regulates protein synthesis during mitosis, and consequently influences cancer cell survival.